Compare J.B.Chemicals with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs CADILA HEALTHCARE - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS CADILA HEALTHCARE J.B.CHEMICALS/
CADILA HEALTHCARE
 
P/E (TTM) x 22.5 28.8 78.0% View Chart
P/BV x 4.0 3.4 117.4% View Chart
Dividend Yield % 0.3 1.0 29.0%  

Financials

 J.B.CHEMICALS   CADILA HEALTHCARE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
CADILA HEALTHCARE
Mar-19
J.B.CHEMICALS/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs363432 84.0%   
Low Rs255306 83.2%   
Sales per share (Unadj.) Rs169.1128.6 131.5%  
Earnings per share (Unadj.) Rs16.618.5 89.5%  
Cash flow per share (Unadj.) Rs23.424.4 96.0%  
Dividends per share (Unadj.) Rs2.003.50 57.1%  
Dividend yield (eoy) %0.60.9 68.3%  
Book value per share (Unadj.) Rs172.5101.5 170.0%  
Shares outstanding (eoy) m83.571,023.74 8.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.82.9 63.6%   
Avg P/E ratio x18.619.9 93.5%  
P/CF ratio (eoy) x13.215.1 87.2%  
Price / Book Value ratio x1.83.6 49.2%  
Dividend payout %12.018.9 63.8%   
Avg Mkt Cap Rs m25,827378,170 6.8%   
No. of employees `0003.812.4 30.3%   
Total wages/salary Rs m2,51121,241 11.8%   
Avg. sales/employee Rs Th3,747.410,585.0 35.4%   
Avg. wages/employee Rs Th665.71,707.8 39.0%   
Avg. net profit/employee Rs Th367.81,526.5 24.1%   
INCOME DATA
Net Sales Rs m14,135131,656 10.7%  
Other income Rs m3662,011 18.2%   
Total revenues Rs m14,501133,667 10.8%   
Gross profit Rs m2,17829,731 7.3%  
Depreciation Rs m5705,986 9.5%   
Interest Rs m351,935 1.8%   
Profit before tax Rs m1,94023,821 8.1%   
Minority Interest Rs m0469 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5525,303 10.4%   
Profit after tax Rs m1,38718,987 7.3%  
Gross profit margin %15.422.6 68.2%  
Effective tax rate %28.522.3 127.9%   
Net profit margin %9.814.4 68.0%  
BALANCE SHEET DATA
Current assets Rs m10,47084,981 12.3%   
Current liabilities Rs m2,74973,425 3.7%   
Net working cap to sales %54.68.8 622.3%  
Current ratio x3.81.2 329.1%  
Inventory Days Days5575 74.1%  
Debtors Days Days78110 70.9%  
Net fixed assets Rs m5,811133,493 4.4%   
Share capital Rs m1671,024 16.3%   
"Free" reserves Rs m14,248102,839 13.9%   
Net worth Rs m14,416103,863 13.9%   
Long term debt Rs m039,497 0.0%   
Total assets Rs m17,649234,831 7.5%  
Interest coverage x56.613.3 425.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.6 142.9%   
Return on assets %8.18.9 90.4%  
Return on equity %9.618.3 52.6%  
Return on capital %13.718.3 74.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16448,404 12.7%   
Fx outflow Rs m1,33411,593 11.5%   
Net fx Rs m4,82936,811 13.1%   
CASH FLOW
From Operations Rs m1,23128,823 4.3%  
From Investments Rs m-208-57,387 0.4%  
From Financial Activity Rs m-59518,846 -3.2%  
Net Cashflow Rs m427-7,105 -6.0%  

Share Holding

Indian Promoters % 55.4 74.8 74.1%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 8.3 40.8%  
FIIs % 3.9 5.9 66.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 11.0 336.4%  
Shareholders   30,437 44,069 69.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SANOFI INDIA  TORRENT PHARMA  FRESENIUS KABI ONCO.  CIPLA  ABBOTT INDIA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 879 Points; Consumer Durables and Metal Stocks Rally(Closing)

Extending gains to the fourth consecutive day, Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Related Views on News

DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Up 0.4% (Market Updates)

Jun 1, 2020 | Updated on Jun 1, 2020

DIVIS LABORATORIES share price has hit an all time high at Rs 2,493 (up 3.5%). The BSE HEALTHCARE Index is up by 0.4%. Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 3.5%) and ABBOTT INDIA (up 0.7%). The top losers include DR. LAL PATHLABS LTD (down 0.2%) and LAURUS LABS LTD (down 0.3%).

J.B.CHEMICALS at All Time High; BSE HEALTHCARE Index Up 0.4% (Market Updates)

Jun 1, 2020 | Updated on Jun 1, 2020

J.B.CHEMICALS share price has hit an all time high at Rs 707 (down 0.3%). The BSE HEALTHCARE Index is up by 0.4%. Among the top gainers in the BSE HEALTHCARE Index today are J.B.CHEMICALS (down 0.3%) and ABBOTT INDIA (up 0.3%). The top losers include AUROBINDO PHARMA (down 0.2%) and SUN PHARMA (down 0.2%).

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 1, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - LUPIN COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS